A simple FISH assay for the detection of 3q26 rearrangements in myeloid malignancy [5]

Leukemia

Volumn 22, Issue 2, 2008, Pages 434-437

  De Melo, V ^a   Vetter, M ^b   Mazzullo, H ^c   Howard, J D ^d   Betts, D R ^e   Nacheva, E P ^d   Apperley, J F ^a   Reid, A G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Kreatech Biotechnology BV   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; DNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW CELL; CENTROMERE; CHROMOSOME 3Q; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME INVERSION; CHROMOSOME MAP; CHROMOSOME REARRANGEMENT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA FLANKING REGION; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOLOGIC MALIGNANCY; HUMAN; KARYOTYPE; LETTER; METAPHASE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS;

EID: 39149137515     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404906     Document Type: Letter

References (8)

1. Morishita K, Parganas E, William CL, Whittaker MH, Drabkin H, Oval J et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilo-bases on chromosome band 3q26. Proc Natl Acad Sci USA 1992; 89: 3937-3941.
2. Barjesteh van Waalwijk van Doom-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: A study of 319 de novo AML patients. Blood 2003; 101: 837-845.
3. Chase A, Grand F, Zhang JG, Blackett N, Goldman J, Gordon M. Factors influencing the false positive and negative rates of BCR-ABL fluorescence in situ hybridization. Genes Chromosomes Cancer 1997; 18: 246-253.
4. Lahortiga I, Vazquez I, Agirre X, Larrayoz MJ, Vizmanos JL, Gozzetti A et al. Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements. Genes Chromosomes Cancer 2004; 40: 179-189.
5. Poppe B, Dastugue N, Vandesompele J, Cauwelier B, De Smet B, Yigit N et al. EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements. Genes Chromosomes Cancer 2006; 45: 349-356.
6. Wieser R, Schreiner U, Rieder H, Pirc-Danoewinata H, Gruner H, Loncarevic IF et al. Interphase fluorescence in situ hybridization assay for tht detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies. Haemaitologica 2003; 88: 25-30.
7. Bobadilla D, Enriquez EL, Alvarez G, Gaytan P, Smith D, Slovak ML. An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies. Br J Haematol 2007; 136: 806-813.
8. Levy EK, Parganas E, Morishita K, Fichelson S, James L, Oscier D et al. DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. Blood 1994; 83: 1348-1354.